A Phase I/II SECSG (southeastern cancer study group). Pilot study of surgical adjuvant immunotherapy with Vaccinia Melanoma Oncolysates (VMO)

M. K. Wallack, K. McNally, M. Michaelides, J. Bash, A. Bartolucci, H. Siegler, C. Balch, H. Wanebo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase I/II SECSG (southeastern cancer study group). Pilot study of surgical adjuvant immunotherapy with Vaccinia Melanoma Oncolysates (VMO)'. Together they form a unique fingerprint.

Medicine & Life Sciences